Funding Rounds
Emergence Therapeutics Series A round, December 2021
Emergence TherapeuticsEmergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
Summary
Stage: Series A
Raised Amount: $92.30M
Raised Date: 2021-12-13